A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer

NCT06474468 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Esophageal Cancer

Interventions

DRUG: SHR-A2102；Adebrelimab；Cisplatin

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.